IN2012DN00448A - - Google Patents

Download PDF

Info

Publication number
IN2012DN00448A
IN2012DN00448A IN448DEN2012A IN2012DN00448A IN 2012DN00448 A IN2012DN00448 A IN 2012DN00448A IN 448DEN2012 A IN448DEN2012 A IN 448DEN2012A IN 2012DN00448 A IN2012DN00448 A IN 2012DN00448A
Authority
IN
India
Prior art keywords
viral protein
fragment
host cell
heterologous expression
cdna
Prior art date
Application number
Inventor
Marcus Hartmann
Christine Sachse
Jenny Apelt
Ulrike Bockau
Original Assignee
Cilian Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cilian Ag filed Critical Cilian Ag
Publication of IN2012DN00448A publication Critical patent/IN2012DN00448A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/60—Vectors containing traps for, e.g. exons, promoters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

"System for the heterologous expression of a viral protein in a ciliate host cell" The present invention relates to a system for the heterologous expression of a viral protein or a fragment thereof, said system comprising a) a ciliate host cell, b) at least one cDNA encoding for a viral protein, or a fragment thereof, and c) a promoter operably linked to said cDNA (Fig. 8)
IN448DEN2012 2009-06-17 2010-06-15 IN2012DN00448A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0910357A GB2471093A (en) 2009-06-17 2009-06-17 Viral protein expression in ciliates
PCT/EP2010/058360 WO2010146043A2 (en) 2009-06-17 2010-06-15 System for the heterologous expression of a viral protein in a ciliate host cell

Publications (1)

Publication Number Publication Date
IN2012DN00448A true IN2012DN00448A (en) 2015-05-15

Family

ID=40940892

Family Applications (1)

Application Number Title Priority Date Filing Date
IN448DEN2012 IN2012DN00448A (en) 2009-06-17 2010-06-15

Country Status (11)

Country Link
US (1) US8377682B2 (en)
EP (1) EP2443232B1 (en)
JP (1) JP2012529899A (en)
CN (2) CN107083393B (en)
CA (1) CA2765799C (en)
DK (1) DK2443232T3 (en)
ES (1) ES2627402T3 (en)
GB (1) GB2471093A (en)
IN (1) IN2012DN00448A (en)
PL (1) PL2443232T3 (en)
WO (1) WO2010146043A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471093A (en) 2009-06-17 2010-12-22 Cilian Ag Viral protein expression in ciliates
US20160186188A1 (en) * 2010-02-09 2016-06-30 Rutgers, The State University Of New Jersey Methods for altering polypeptide expression and solubility
JP6841184B2 (en) * 2017-08-07 2021-03-10 日立金属株式会社 Manufacturing method of semiconductor devices
CN108130340B (en) * 2018-02-06 2021-02-23 福建省农业科学院畜牧兽医研究所 Method for expressing duck source avian influenza virus NS1 protein and application of method
CN114569710A (en) * 2022-03-09 2022-06-03 华南农业大学 Preparation method of Cryptocaryon irritans vaccine based on tetrahymena thermophila tubulin protein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752473A (en) 1984-10-12 1988-06-21 The Regents Of The University Of California Expression of glycosylated human influenza hemagglutinin proteins
EP0670901A1 (en) * 1993-03-11 1995-09-13 Akzo Nobel N.V. Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
AU2756100A (en) 1999-02-04 2000-08-25 Cornell Research Foundation Inc. Diagnostic and protective antigen gene sequences of ichthyophthirius
WO2003006480A1 (en) * 2001-07-13 2003-01-23 University Of Rochester Tetrahymena metallothionein gene promoter and its use
PT1465987E (en) * 2001-12-07 2008-04-15 Crucell Holland Bv Production of viruses, viral isolates and vaccines
US20060127973A1 (en) * 2002-03-19 2006-06-15 Marcus Hartmann Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof
DE10214406A1 (en) * 2002-03-30 2003-10-09 Nutrinova Gmbh Preparation of recombinant protists, useful for preparation of recombinant proteins, by transforming auxotrophic mutant with DNA that complements the auxotrophy
DE10214413A1 (en) * 2002-03-30 2003-10-09 Nutrinova Gmbh Expression of recombinant human proteins in Tetrahymena
AU2006268587A1 (en) * 2005-07-13 2007-01-18 Cilian Ag Tetrahymena heat inducible promoters and their use
EP1945250A4 (en) * 2005-08-16 2010-05-19 Hawaii Biotech Inc RECOMBINANT SUBUNIT VACCINE FOR INFLUENZA VIRUS
US20070286873A1 (en) * 2006-05-23 2007-12-13 Williams John V Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
BRPI0815662A2 (en) * 2007-08-20 2016-09-27 Fraunhofer Usa Inc flu vaccines, antigens, compositions, and prophylactic and therapeutic methods
GB2471093A (en) 2009-06-17 2010-12-22 Cilian Ag Viral protein expression in ciliates

Also Published As

Publication number Publication date
US20110008835A1 (en) 2011-01-13
JP2012529899A (en) 2012-11-29
CN102712909A (en) 2012-10-03
WO2010146043A3 (en) 2011-02-17
GB0910357D0 (en) 2009-07-29
DK2443232T3 (en) 2017-05-22
CA2765799C (en) 2018-04-03
CA2765799A1 (en) 2010-12-23
US8377682B2 (en) 2013-02-19
GB2471093A (en) 2010-12-22
CN107083393B (en) 2021-12-10
EP2443232B1 (en) 2017-03-01
ES2627402T3 (en) 2017-07-28
CN107083393A (en) 2017-08-22
EP2443232A2 (en) 2012-04-25
WO2010146043A2 (en) 2010-12-23
PL2443232T3 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
EP3971286A3 (en) Nipah virus envelope pseudotyped lentiviruses and methods of use
MY161268A (en) PEPTIDE OR PEPTIDE COMPLEX BINDING TO α2 INTEGRIN AND METHODS AND USES INVOLVING THE SAME
TW200738753A (en) Methods for modulating mannose content of recombinant proteins
MX2015004060A (en) 3-epimerase.
GB201003701D0 (en) System for the expression of a protein
MY169472A (en) Refolding of recombinant proteins
NZ584893A (en) PORCINE DC-SIGN, ICAM-3 AND LSECtin AND USES THEREOF
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
EP2470670A4 (en) Coagulation factor vii compositions and methods of making and using same
MX2010001284A (en) Multimeric multiepitope influenza vaccines.
WO2008121324A3 (en) Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
NZ599774A (en) Melanocortin-1 receptor-specific cyclic peptides
MY160897A (en) Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
MX336112B (en) Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same.
MX2012002565A (en) Enhanced protein purification through a modified protein a elution.
MX2009013329A (en) Heterologous and homologous cellulase expression system.
IN2012DN03093A (en)
WO2013093760A3 (en) Compositions, methods, and kits for preparing sialylated recombinant proteins
IN2012DN00448A (en)
NZ717399A (en) Antibodies against csf-1r
CO6430475A2 (en) POLIPEPTIDES THAT HAVE CELLULASE ACTIVITY
CL2012001609A1 (en) Epstein-barr virus (eb) -induced tumor fusion polypeptide formed by the binding of mutant colicin ia polypeptide, which can form ion channels, and which has the g11a, h22g, a26g, v31l and h40d mutations, with an antibody anti-eb virus or an anti-eb virus antibody mimetic polypeptide; coding gene for said polypeptide; recombination plasmid comprising said gene; method of preparing said polypeptide; medical use of said polypeptide; colicin ia mutant polypeptide with sec id # 24 (with mutations g11a, h22g, a26g, v31l and h40d mutations); coding gene for said polypeptide; medical use of said gene.
MX2015005266A (en) Fc gamma receptor iib variants.
IN2012DN03358A (en)